Managing Market Risks

Managed-care stocks offer value in an uncertain economy

Consistent demand for health care and the companies' ability to annually adjust pricing are attractive attributes in an uncertain economic backdrop, says Fidelity's Sean Gavin.

  • Fidelity Portfolio Manager Sean Gavin is finding compelling investment opportunities in the health care sector, especially in the managed-care industry, where stocks widely lagged the broader U.S. equity market in 2023.
  • "The weak return for managed care reflects the market's concern about a drop in Medicare reimbursement and an increase in the utilization of outpatient care," explains Gavin, who manages Fidelity Advisor® Value Leaders Fund. "But I think this sell-off may be misguided, and that investors are overreacting to what I consider a short-term challenge for this segment."
  • As manager of the large cap, value-oriented strategy since 2014, Gavin invests in companies when he sees significant price dislocation, believing that a stock's market value will move toward its intrinsic (fair) value over time.
  • In his view, many investors insufficiently recognize that managed-care companies operate on annual contracts, which gives them flexibility to regularly adjust pricing and pass through their additional costs or adjust their benefits, as the market allows, to boost profitability over the long term.
  • Gavin appreciates the historically steady nature of the managed-care business, as demand for health care services is inherently more predictable and less vulnerable to economic cycles than other sectors. He sees this as a particularly valuable attribute in a weakening economy.
  • "In this challenging economic environment, where we don't know whether the Federal Reserve will achieve a "soft landing" after its aggressive rate-increase campaign, I see managed-care stocks as defensive investments with the potential to generate an attractive return over time," says Gavin.
  • Also appealing to Gavin is that lowered stock valuations give managed-care providers the opportunity to buy back their own stock at an attractive price, offering a path for these companies to boost their intrinsic value.
  • As of November 30, the fund had meaningful stakes in a handful of managed-care providers—Cigna, Centene, Elevance Health, UnitedHealth Group, and Humana—totaling roughly 16% of its net assets.
  • "I'm happy to hold these stocks in the fund through their current period of difficulty, particularly given their depressed valuations, and wait patiently for what I believe could be favorable long-term results," says Gavin.
  • For specific fund information such as standard performance and holdings, please go to the "Funds Managed" link on this page.

There was an issue with your input


Please confirm